Takeda Pharmaceutical
TAK
#452
Rank
NZ$92.82 B
Marketcap
NZ$27.89
Share price
-1.54%
Change (1 day)
22.23%
Change (1 year)

Market capitalization of Takeda Pharmaceutical (TAK)

Market cap: NZ$92.82 Billion

As of January 2026 Takeda Pharmaceutical has a market cap of NZ$92.82 Billion. This makes Takeda Pharmaceutical the world's 452th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Takeda Pharmaceutical from 2008 to 2026

End of year Market Cap

Year Marketcap Change
2026NZ$92.82 B3.23%
2025NZ$89.92 B20.43%
2024NZ$74.66 B4.8%
2023NZ$71.24 B-6.74%
2022NZ$76.39 B22.17%
2021NZ$62.53 B-20.73%
2020NZ$78.88 B-14.26%
2019NZ$92.01 B135.28%
2018NZ$39.10 B-37.29%
2017NZ$62.36 B32.6%
2016NZ$47.03 B-18.66%
2015NZ$57.82 B37.21%
2014NZ$42.14 B-4.6%
2013NZ$44.17 B2.68%
2012NZ$43.02 B-3.54%
2011NZ$44.60 B-10.49%
2010NZ$49.82 B11.56%
2009NZ$44.66 B-43.4%
2008NZ$78.91 B

End of Day market cap according to different sources

On Jan 12th, 2026 the market cap of Takeda Pharmaceutical was reported to be:

NZ$89.16 Billion
by Nasdaq info icon info icon
NZ$94.27 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Johnson & Johnson
JNJ
NZ$896.84 B 866.16%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
NZ$199.24 B 114.64%๐Ÿ‡ซ๐Ÿ‡ท France
Pfizer
PFE
NZ$249.14 B 168.40%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
NZ$473.41 B 410.01%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Seagen
SGEN
NZ$75.18 B-19.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Dr. Reddy's Laboratories
RDY
NZ$19.18 B-79.33%๐Ÿ‡ฎ๐Ÿ‡ณ India
Amgen
AMGN
NZ$304.25 B 227.77%๐Ÿ‡บ๐Ÿ‡ธ USA
GlaxoSmithKline
GSK
NZ$175.71 B 89.29%๐Ÿ‡ฌ๐Ÿ‡ง UK
Merck
MRK
NZ$471.13 B 407.55%๐Ÿ‡บ๐Ÿ‡ธ USA